|
May 01, 2024
|
|
|
|
CLRA 583 Regulatory Affairs in Drug Development III This course is part of a 3-course sequence that provides a working knowledge of pharmaceutical regulatory affairs. Emphasis is on a US development, although topics will include non-US development and the development of biologics, OTC and devices. This course addresses post-approval issues including advertising and promotion, drug safety and pricing.
Credit 3 hrs May not be repeated for additional credit Grade Mode Normal (A-F) Course Rotation Fall
Prerequisites - CLRA 581 and CLRA 582 Other Restrictions - Restriction by Major - Restriction by Degree Type - Masters, Graduate Certificate, Degree Admit - Condition 4, UG Degree Pending
Updates: Course Rotation added 9/2014, 7/2011; May 2011
Summer 2024 Course Sections
Fall 2024 Course Sections
Add to Portfolio (opens a new window)
|
|